Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Accenture
Chubb
AstraZeneca
Healthtrust
Queensland Health
Baxter
Julphar
QuintilesIMS
Harvard Business School

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,288,505

« Back to Dashboard

Summary for Patent: 5,288,505
Title: Extended release form of diltiazem
Abstract:An extended-release galenical form of Diltiazem or a pharmaceutically acceptable salt thereof, which comprises beads containing said Diltiazem or a pharmaceutically acceptable salt thereof as an active ingredient and a wetting agent, said beads being coated with a microporous membrane comprising at least a water-soluble or water-dispersible polymer or copolymer and a pharmaceutically acceptable adjuvant.
Inventor(s): Deboeck; Arthur M. (Gurabo, PR), Baudier; Philippe R. (Waterloo, BE)
Assignee: Galephar P.R., Inc., Ltd. (Carolina, PR)
Application Number:07/721,396
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

Drugs Protected by US Patent 5,288,505

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,288,505

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2243092 ➤ Sign Up
Canada 2111085 ➤ Sign Up
Germany 69229949 ➤ Sign Up
Austria 184196 ➤ Sign Up
Denmark 0591424 ➤ Sign Up
European Patent Office 0591424 ➤ Sign Up
World Intellectual Property Organization (WIPO) 9300093 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chinese Patent Office
Teva
Baxter
Cerilliant
Argus Health
Cipla
AstraZeneca
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot